menu ☰
menu ˟

Tocilizumab linked to lower cardiovascular risk than TNF inhibitors in RA

16 Apr 2019
Among patients with rheumatoid arthritis, tocilizumab was associated with a decreased risk for major adverse cardiovascular events, compared with TNF inhibitors, whereas conventional synthetic disease-modifying antirheumatic drugs may be linked with ...

Click here to view the full article which appeared in Cardiology

Please note

The news articles accessible on the Health Well website have been compiled from various sources that are not controlled by the Institute of Public Health in Ireland (IPH). IPH is therefore not responsible for the content of external websites and the inclusion of a link to an external website from the Health Well should not be understood to be an endorsement of that website.